Get the Stockscreener App
1.70
3.96%
0.06
Metagenomi Inc stock is traded at $1.70, with a volume of 149.00K.
It is up +3.96% in the last 24 hours and up +0.29% over the past month.
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
See More
Previous Close:
$1.64
Open:
$1.66
24h Volume:
149.00K
Relative Volume:
0.22
Market Cap:
$64.15M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.01%
1M Performance:
+0.29%
6M Performance:
+15.20%
1Y Performance:
-45.18%
1-Day Range:
$1.655
$1.72
1-Week Range:
$1.61
$1.77
52-Week Range:
$1.23
$4.40
Metagenomi Inc Stock (MGX) Company Profile
Name
Metagenomi Inc
Sector
Industry
Phone
(510) 871-4880
Address
5959 HORTON STREET, EMERYVILLE
Compare MGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
1.7085 | 61.58M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.45 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.90 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.26 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
852.73 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
168.14 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-24 | Initiated | H.C. Wainwright | Buy |
| May-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-05-24 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-24 | Initiated | Chardan Capital Markets | Buy |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Mar-05-24 | Initiated | Jefferies | Buy |
| Mar-05-24 | Initiated | TD Cowen | Outperform |
| Mar-05-24 | Initiated | Wells Fargo | Overweight |
View All
Metagenomi Inc Stock (MGX) Latest News
Is Metagenomi Inc. stock recession proofPortfolio Performance Summary & Stepwise Trade Signal Implementation - Улправда
Why analysts upgrade Metagenomi Inc. stock2025 Volume Leaders & AI Enhanced Market Trend Forecasts - Улправда
Metagenomi, Inc. (NASDAQ:MGX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Thomas Brian C. sells $6786 in Metagenomi (MGX) stock By Investing.com - Investing.com Nigeria
Metagenomi CFO Wapnick sells $2792 in shares By Investing.com - Investing.com Australia
Irish Jian, Metagenomi CEO, sells $2838 in MGX stock By Investing.com - Investing.com Australia
Metagenomi general counsel Wein sells $352 in stock By Investing.com - Investing.com Nigeria
Thomas Brian C. sells $6786 in Metagenomi (MGX) stock - Investing.com
Irish Jian, Metagenomi CEO, sells $2838 in MGX stock - Investing.com India
Metagenomi general counsel Wein sells $352 in stock - Investing.com
Will Metagenomi Inc. stock deliver consistent dividendsBull Run & Technical Pattern Based Signals - Newser
Pura Vida Investments LLC Grows Stock Position in Metagenomi, Inc. $MGX - MarketBeat
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock By Investing.com - Investing.com UK
Metagenomi’s general counsel Wein sells $360 in stock By Investing.com - Investing.com Nigeria
Thomas Brian C. sells Metagenomi (MGX) shares worth $4888 By Investing.com - Investing.com Canada
Metagenomi CFO Wapnick sells $2852 in shares By Investing.com - Investing.com Canada
Thomas Brian C. sells Metagenomi (MGX) shares worth $4888 - Investing.com India
Metagenomi CFO Wapnick sells $2852 in shares - Investing.com
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock - Investing.com
CEO Irish Surrenders 1,602 Of Metagenomi Inc [MGX] - TradingView
Metagenomi’s general counsel Wein sells $360 in stock - Investing.com
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference - marketscreener.com
Metagenomi (Nasdaq: MGX) to unveil APOC3 preclinical data from Ionis collaboration at 2025 Nature conference - Stock Titan
Will Metagenomi Inc. stock attract ESG investorsQuarterly Earnings Report & Reliable Intraday Trade Plans - moha.gov.vn
Metagenomi, Inc. (MGX) 5.71% in After-hours: Strong Investor Interest - Stocks Telegraph
Metagenomi Inc Stock Analysis and ForecastMomentum Trading Signals & Predict Price Movements With AI Precision - earlytimes.in
Why Metagenomi Inc. stock could rally in 2025July 2025 Volume & Verified High Yield Trade Plans - newser.com
Market reaction to Metagenomi Inc.’s recent newsLong Setup & Weekly Setup with ROI Potential - newser.com
What sentiment indicators say about Metagenomi Inc. stockJuly 2025 Movers & Technical Pattern Based Buy Signals - newser.com
How to forecast Metagenomi Inc. trends using time seriesBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
Is Metagenomi Inc. stock a safe haven assetQuarterly Trade Review & Free Daily Entry Point Trade Alerts - newser.com
How Metagenomi Inc. stock performs in stagflationQuarterly Profit Report & Capital Efficiency Focused Strategies - newser.com
Is Metagenomi Inc. stock gaining market shareJuly 2025 Breakouts & Technical Buy Zone Confirmations - newser.com
Exit strategy if you’re trapped in Metagenomi Inc.Market Trend Review & Weekly Hot Stock Watchlists - newser.com
How Metagenomi Inc. stock performs in rising dollar environmentJuly 2025 Selloffs & Expert-Curated Trade Recommendations - newser.com
Using AI based signals to follow Metagenomi Inc.July 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
Ready to Jump After Recent Trade: Metagenomi Inc (MGX) - Setenews
Jefferies lowers Metagenomi stock price target to $9 from $21 on pipeline timing - Investing.com Nigeria
Metagenomi Inc Stock (MGX) Financials Data
There is no financial data for Metagenomi Inc (MGX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.44%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):